Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Salman

Showing results (371-380 of 387) with videos related to

Pageof 39
Sort By:
Infection and Immunity|November 30, 2016
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking VaccinesDiego A Espinosa, Joel Vega-Rodriguez, Yevel Flores-Garcia, et al.
Frontiers in Cellular and Infection Microbiology|June 27, 2020
Generation of Novel <i>Plasmodium falciparum</i> NF135 and NF54 Lines Expressing Fluorescent Reporter Proteins Under the Control of Strong and Constitutive PromotersShinya Miyazaki, Annie S P Yang, Fiona J A Geurten, et al.
Frontiers in Cellular and Infection Microbiology|May 7, 2019
A <i>P. falciparum</i> NF54 Reporter Line Expressing mCherry-Luciferase in Gametocytes, Sporozoites, and Liver-StagesCatherin Marin-Mogollon, Ahmed M Salman, Karin M J Koolen, et al.
Science Translational Medicine|September 28, 2018
Prime and target immunization protects against liver-stage malaria in miceAnita Gola, Daniel Silman, Adam A Walters, et al.
Frontiers in Cellular and Infection Microbiology|January 4, 2021
Generation of a Genetically Modified Chimeric <i>Plasmodium falciparum</i> Parasite Expressing <i>Plasmodium vivax</i> Circumsporozoite Protein for Malaria Vaccine DevelopmentYukiko Miyazaki, Catherin Marin-Mogollon, Takashi Imai, et al.
Cancer Research|April 6, 2026
SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell CarcinomaBrian M Ortmann, Tekle Pauzaite, James A C Bertlin, et al.
Leukemia|October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaG Fraser, P Cramer, F Demirkan, et al.
Wellcome Open Research|April 13, 2026
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adultsDaniel Silman, Amy Flaxman, Mehreen Datoo, et al.
NPJ Vaccines|August 30, 2018
A <i>Plasmodium berghei</i> sporozoite-based vaccination platform against human malariaAntónio M Mendes, Marta Machado, Nataniel Gonçalves-Rosa, et al.
Emerging Infectious Diseases|March 14, 2023
Outbreaks of SARS-CoV-2 Infections in Nursing Homes during Periods of Delta and Omicron Predominance, United States, July 2021-March 2022W Wyatt Wilson, Amelia A Keaton, Lucas G Ochoa, et al.
Pageof 39

Showing results (371-380 of 387) with videos related to

Sort By:
Pageof 39
Infection and Immunity|November 30, 2016
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking VaccinesDiego A Espinosa, Joel Vega-Rodriguez, Yevel Flores-Garcia, et al.
Frontiers in Cellular and Infection Microbiology|June 27, 2020
Generation of Novel <i>Plasmodium falciparum</i> NF135 and NF54 Lines Expressing Fluorescent Reporter Proteins Under the Control of Strong and Constitutive PromotersShinya Miyazaki, Annie S P Yang, Fiona J A Geurten, et al.
Frontiers in Cellular and Infection Microbiology|May 7, 2019
A <i>P. falciparum</i> NF54 Reporter Line Expressing mCherry-Luciferase in Gametocytes, Sporozoites, and Liver-StagesCatherin Marin-Mogollon, Ahmed M Salman, Karin M J Koolen, et al.
Science Translational Medicine|September 28, 2018
Prime and target immunization protects against liver-stage malaria in miceAnita Gola, Daniel Silman, Adam A Walters, et al.
Frontiers in Cellular and Infection Microbiology|January 4, 2021
Generation of a Genetically Modified Chimeric <i>Plasmodium falciparum</i> Parasite Expressing <i>Plasmodium vivax</i> Circumsporozoite Protein for Malaria Vaccine DevelopmentYukiko Miyazaki, Catherin Marin-Mogollon, Takashi Imai, et al.
Cancer Research|April 6, 2026
SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell CarcinomaBrian M Ortmann, Tekle Pauzaite, James A C Bertlin, et al.
Leukemia|October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaG Fraser, P Cramer, F Demirkan, et al.
Wellcome Open Research|April 13, 2026
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adultsDaniel Silman, Amy Flaxman, Mehreen Datoo, et al.
NPJ Vaccines|August 30, 2018
A <i>Plasmodium berghei</i> sporozoite-based vaccination platform against human malariaAntónio M Mendes, Marta Machado, Nataniel Gonçalves-Rosa, et al.
Emerging Infectious Diseases|March 14, 2023
Outbreaks of SARS-CoV-2 Infections in Nursing Homes during Periods of Delta and Omicron Predominance, United States, July 2021-March 2022W Wyatt Wilson, Amelia A Keaton, Lucas G Ochoa, et al.
Pageof 39